Literature DB >> 17112771

Evolution of the management of laryngeal cancer.

Eric M Genden1, Alfio Ferlito, Carl E Silver, Adam S Jacobson, Jochen A Werner, Carlos Suárez, C René Leemans, Patrick J Bradley, Alessandra Rinaldo.   

Abstract

The treatment of laryngeal cancer has evolved through several phases, starting with wide extirpative surgical resection, and evolving through an era of conservation surgery and, finally, planned treatment using modalities of irradiation, chemotherapy and surgery in various combinations. Attempts to extirpate laryngeal cancer date to the nineteenth century, but only by the mid-twentieth century did advances in anesthesia, blood transfusion and antibiotics, make this surgery safe and reliable. Techniques of partial laryngectomy by external approach developed in the second half of the twentieth century, and endoscopic use of the laser refined the concept and provided a new paradigm for surgical treatment, particularly for early lesions. During most of this era, radiation was employed as an alternative method of treatment, with surgery reserved for salvage of radiation failure. By the last decade of the twentieth century, and to the present time, the value of combined modality therapy, using planned combinations of irradiation, chemotherapy and surgery became the standard of care for advanced laryngeal cancer, permitting maximal laryngeal preservation with the highest attainable cure rates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112771     DOI: 10.1016/j.oraloncology.2006.08.007

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  27 in total

1.  MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma.

Authors:  Shuo Wu; Shenshan Jia; Ping Xu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Head and neck cancer: an evolving treatment paradigm.

Authors:  David M Cognetti; Randal S Weber; Stephen Y Lai
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

3.  Oncologic results and quality of life in patients with T3 glottic cancer after transoral laser microsurgery.

Authors:  Pei-Ju Chien; Li-Ting Hung; Ling-Wei Wang; Muh-Hwa Yang; Pen-Yuan Chu
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-06       Impact factor: 2.503

Review 4.  [Imaging of the head and neck region].

Authors:  M Lell; K Mantsopoulos; M Uder; W Wuest
Journal:  HNO       Date:  2016-03       Impact factor: 1.284

5.  Novel modification of voice prosthesis.

Authors:  Basel Al Kadah; George Papaspyrou; Mathias Schneider; Bernhard Schick
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-13       Impact factor: 2.503

6.  Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.

Authors:  Lianqing Li; Jing Wang; Lei Gao; Lili Gong
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

7.  Rehabilitation of dysphagia following head and neck cancer.

Authors:  Barbara R Pauloski
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-11       Impact factor: 1.784

8.  CXCR4 silencing inhibits invasion and migration of human laryngeal cancer Hep-2 cells.

Authors:  Juntao Niu; Yongwang Huang; Lun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  The association between XRCC1 polymorphism and laryngeal cancer susceptibility in different ethnic groups in Xinjiang, China.

Authors:  Nilipaer Alimu; Ayiheng Qukuerhan; Song Wang; Yasin Abdurehim; Pilidong Kuyaxi; Bo Zhang; Yalikun Yasheng
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

Review 10.  [Imaging of the head and neck region].

Authors:  M Lell; K Mantsopoulos; M Uder; W Wuest
Journal:  Radiologe       Date:  2016-02       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.